| Resorufin ethyl ether
| 5725-91-7 | A972195 |
| Resveratrol
| 501-36-0 | A970038 |
| Retinoic acid
| 302-79-4 | A1019947 |
| Retinol
| 68-26-8 | A1020043 |
| Reuterin
| 2134-29-4 | A969201 |
| Rhamnose
| 3615-41-6 | A972560 |
| Rhein
| 478-43-3 | A971596 |
| Rhenium(VI) oxide 99.9%
| 1314-28-9 | A969718 |
| Rhodamine 110 chloride
| 13558-31-1 | A974243 |
| Rhodamine 123
| 62669-70-9 | A983282 |
| Rhodamine 6G
| 989-38-8 | A1028878 |
| Rhodamine B
| 81-88-9 | A972207 |
| Rhodanine
| 141-84-4 | A978795 |
| Rhodium trichloride hydrate
| 20765-98-4 | A1020200 |
| Rhodium(1+), [(1,2,5,6-η)-1,5-cyclooctadiene][(2S,2′S,5S,5′S)-1,1′-(1,2-phenylene)bis[2,5-diethylphospholane-κP]]-, salt with trifluoromethanesulfonic acid (1:1) (9CI)
| 142184-30-3 | A1124919 |
| Rhodium(1+), [1,1′-bis[bis(1-methylethyl)phosphino-κP]ferrocene][(1,2,5,6-η)-1,5-cyclooctadiene]-, tetrafluoroborate(1-) (1:1) (ACI)
| 255064-36-9 | A1042254 |
| Rhodium(3+), tris(acetonitrile)[[2-[(diphenylphosphino-κP)methyl]-2-methyl-1,3-propanediyl]bis[diphenylphosphine-κP]]-, (OC-6-22)-, salt with trifluoromethanesulfonic acid (1:3) (9CI)
| 128137-75-7 | A1074804 |
| Rhodium(II) trifluoroacetate dimer
| 31126-95-1 | A972231 |
| Rhodium(II) trimethylacetate, dimer
| 62728-88-5 | A979145 |
| Rhodium(II) triphenylacetate dimer
| 142214-04-8 | A972856 |
| Rhodium(iii) 2-ethylhexanoate
| 20845-92-5 | A975051 |
| Rhodium(III) chloride trihydrate
| 13569-65-8 | A972036 |
| Rhodium(III) iodide
| 15492-38-3 | A974640 |
| Rhodizonic acid disodium
| 523-21-7 | A969807 |
| Riboflavin
| 83-88-5 | A1019953 |
| Riboflavin sodium phosphate
| 130-40-5 | A1081417 |
| Rilpivirine
| 500287-72-9 | A1020157 |
| RINK AMIDE AM RESIN
| 183599-10-2 | A1037395 |
| Rink Amide MBHA Resin, Loading 0.5-0.8 mmol/g
| N/A | A1105044 |
| Rink Amide MBHA Resin; Loading 0.2-0.4mmol/g (Low loading)
| N/A | A1105045 |
| Ritolukast
| 111974-60-8 | A1028243 |
| Ritonavir
| 155213-67-5 | A1034161 |
| RIVAROXABAN AMINE
| 898543-06-1 | A977815 |
| Rivaroxaban Related Compound G
| 446292-08-6 | A983010 |
| Rivastigmine
| 123441-03-2 | A975016 |
| Rivastigmine Related Compound A
| 32634-68-7 | A977591 |
| Rivastigmine Related Compound C
| 139306-10-8 | A975408 |
| Rivastigmine Related Compound D
| 855300-09-3 | A979923 |
| RockPhos
| 1262046-34-3 | A969585 |
| RockPhos Pd G3 ChemBeads
| 2009020-38-4 | A970789 |
| Rofecoxib
| 162011-90-7 | A1019923 |
| Ropivacaine Related Compound A
| 21436-98-6 | A976535 |
| Ropivacaine Related Compound B
| 112773-90-7 | A972283 |
| Rosuvastatin calcium
| 147098-20-2 | A1020143 |
| Rosuvastatin impurity 54
| 799842-07-2 | A985119 |
| Rosuvastatin Sodium
| 147098-18-8 | A1037263 |
| Ru(II)-(S)-Pheox Catalyst
| 1259070-80-8 | A974052 |
| Rubidium chloride
| 7791-11-9 | A969609 |
| RuCl(p-cymene)[(S,S)-MsDpen]
| 329371-25-7 | A969996 |
| RuCl(p-cymene)[(S,S)-Ts-DPEN]
| 192139-90-5 | A970796 |
| RuCl2[(R)−DM−BINAP][(R,R)−DPEN]
| 220114-38-5 | A980687 |
| RuCl[(R,R)-TsDPEN](mesitylene)
| 174813-82-2 | A970072 |
| RuCl[(S,S)-TsDPEN](mesitylene)
| 174813-81-1 | A969199 |
| RuPhos
| 787618-22-8 | A969208 |
| RuPhos Pd G2
| 1375325-68-0 | A889781 |
| RuPhos Pd G3
| 1445085-77-7 | A968915 |
| RuPhos Pd G4 ChemBeads
| 1599466-85-9 | A969263 |
| Ruthenium chloride
| 10049-08-8 | A35166 |
| Ruthenium dioxide hydrate
| 32740-79-7 | A1015213 |
| Ruthenium trichloride hydrate
| 14898-67-0 | A1050881 |
| Ruthenium trichloride monohydrate
| 20759-14-2 | A1019977 |
| Ruthenium(1+), tetrakis(acetonitrile)[2-[(4R)-4,5-dihydro-4-phenyl-2-oxazolyl-κN3]phenyl-κC]-, (OC-6-23)-, hexafluorophosphate(1-) (1:1) (ACI)
| 1421679-43-7 | A1008603 |
| Ruthenium(2+), tris(2,2′-bipyrazine-κN1,κN1′)-, (OC-6-11)-, hexafluorophosphate(1-) (1:2) (ACI)
| 80907-56-8 | A529230 |
| Ruthenium(2+), tris(2,2′-bipyridine-κN1,κN1′)-, (OC-6-11)-, tetrafluoroborate(1-) (1:2) (ACI)
| 63950-81-2 | A1108455 |
| Ruthenium(III) acetate
| 72196-32-8 | A970160 |
| Ruthenium(III) chloride trihydrate
| 13815-94-6 | A970007 |
| ruthenium(VIII) oxide
| 20427-56-9 | A966146 |
| Ruthenium, [(1S,2S)-N1,N2-bis[[2-(diphenylphosphino-κP)phenyl]methylene]-1,2-cyclohexanediamine-κN1,κN2]dichloro-, (OC-6-13)- (ACI)
| 174677-80-6 | A1015096 |
| Ruthenium, [1,1′-(1S)-[1,1′-binaphthalene]-2,2′-diylbis[1,1-diphenylphosphine-κP]]dichloro[(1R,2R)-1,2-diphenyl-1,2-ethanediamine-κN1,κN2]-, (OC-6-13)- (ACI)
| 329735-87-7 | A1032177 |
| Ruthenium, [N-[(1R,2R)-2-(amino-κN)cyclohexyl]-4-methylbenzenesulfonamidato-κN]chloro[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]- (9CI, ACI)
| 213603-12-4 | A1085667 |
| Ruthenium, [N-[(1R,2R)-2-amino-1,2-diphenylethyl]-4-methylbenzenesulfonamidato(2-)-κN][(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]- (9CI, ACI)
| 195516-84-8 | A1009202 |
| Ruthenium, [N-[(1S,2S)-2-(amino-κN)-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzenesulfonamidato-κN]chloro[(1,2,3,4,5,6-η)-1-methyl-4-(1-methylethyl)benzene]- (ACI)
| 1026995-72-1 | A984291 |
| Ruthenium, chloro[N-[(1R,2R)-1,2-diphenyl-2-[(S)-[4-(η6-phenyl)butyl]amino-κN]ethyl]-4-methylbenzenesulfonamidato-κN]-, stereoisomer (ACI)
| 1000286-39-4 | A1065737 |
| Ruthenium, chloro[N-[(1R,2R)-2-[(S)-[2-[[(1,2,3,4,5,6-η)-4-methylphenyl]methoxy]ethyl]amino-κN]-1,2-diphenylethyl]methanesulfonamidato-κN]-, stereoisomer (ACI)
| 1333981-86-4 | A1042092 |
| Ruthenium, chloro[N-[(1S,2S)-1,2-diphenyl-2-[(R)-[3-(η6-phenyl)propyl]amino-κN]ethyl]-4-methylbenzenesulfonamidato-κN]-, stereoisomer (9CI, ACI)
| 851051-43-9 | A1060148 |
| Ruthenium, tetracarbonyl-μ-hydro[(1,2,3,4,5-η)-1-hydroxylato-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-yl][(1,2,3,4,5-η)-1-hydroxy-2,3,4,5-tetraphenyl-2,4-cyclopentadien-1-yl]di- (9CI, ACI)
| 104439-77-2 | A989655 |
| Ruxolitinib | 941678-49-5 | A1020023 |
